We develop creative technologies that combine stem cell biology, CRISPR-Cas9 genome editing screens, and computational biology to understand gene function and regulation and contribute to new gene-based therapeutics for complex disease.
Goals
To predict how changes in genome sequence alter gene expression, cellular function, and human disease.
To identify strategies to alter genome function to ameliorate complex disease phenotypes.
